81 related articles for article (PubMed ID: 21137246)
21. Comparisons between anthropometric indices for predicting the metabolic syndrome in Japanese.
Kato M; Takahashi Y; Inoue M; Tsugane S; Kadowaki T; Noda M;
Asia Pac J Clin Nutr; 2008; 17(2):223-8. PubMed ID: 18586640
[TBL] [Abstract][Full Text] [Related]
22. [Screening and sampling of endometrial carcinoma accuracy of the endometrial cytology test for the screening of endometrial cancer].
Yang X; Liao QP; Wu C; Zhang NY; Zhao J; Chen R; Zhang N; Ma XH; Gao YN; Gao WL; Zheng H; Zeng Z; Wen J; Dong Y
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):884-90. PubMed ID: 24495678
[TBL] [Abstract][Full Text] [Related]
23. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
24. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
Li Z; Deng ML; Tseng CH; Heber D
Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
[TBL] [Abstract][Full Text] [Related]
25. Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study.
Shan W; Ning C; Luo X; Zhou Q; Gu C; Zhang Z; Chen X
Gynecol Oncol; 2014 Mar; 132(3):606-10. PubMed ID: 24418201
[TBL] [Abstract][Full Text] [Related]
26. Molecular biomarkers in endometrial hyperplasias predict cancer progression.
Steinbakk A; Gudlaugsson E; Aasprong OG; Skaland I; Malpica A; Feng W; Janssen EA; Baak JP
Am J Obstet Gynecol; 2011 Apr; 204(4):357.e1-12. PubMed ID: 21324435
[TBL] [Abstract][Full Text] [Related]
27. Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia.
Chen YL; Cheng WF; Lin MC; Huang CY; Hsieh CY; Chen CA
J Formos Med Assoc; 2009 Jun; 108(6):502-7. PubMed ID: 19515631
[TBL] [Abstract][Full Text] [Related]
28. Complex hyperplasia of the endometrium. Predictive value of curettage vs. hysterectomy specimens.
Lambert B; Muteganya D; Lepage Y; Boivin Y
J Reprod Med; 1994 Aug; 39(8):639-42. PubMed ID: 7996530
[TBL] [Abstract][Full Text] [Related]
29. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
30. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
Borisov I; Maĭnkhard K; Tsankova M
Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
32. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
33. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma].
Zhao JH; Wan XY; Xie X; Zhou CY; Wu QY
Ai Zheng; 2006 Jun; 25(6):753-7. PubMed ID: 16764775
[TBL] [Abstract][Full Text] [Related]
35. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
36. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
38. Loss of Smad4 protein expression occurs infrequently in endometrial carcinomas.
Liu FS; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Int J Gynecol Pathol; 2003 Oct; 22(4):347-52. PubMed ID: 14501814
[TBL] [Abstract][Full Text] [Related]
39. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.
Minaguchi T; Nakagawa S; Takazawa Y; Nei T; Horie K; Fujiwara T; Osuga Y; Yasugi T; Kugu K; Yano T; Yoshikawa H; Taketani Y
Cancer Lett; 2007 Apr; 248(1):112-22. PubMed ID: 16919866
[TBL] [Abstract][Full Text] [Related]
40. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
Choudhury M; Bansal S
Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
